coin use- Top People searches

South Korean President Yin Xiyue: The purpose of the opposition's impeachment is to evade the legal responsibility of its leader Li Zaiming by holding an early general election.Huichuan Technology: The company has made great efforts to broaden the products and applications of six-axis robots, and the six-axis robots with small loads have achieved mass sales. Huichuan Technology said on the interactive platform that the company has made great efforts to broaden the products and applications of six-axis robots, and the six-axis robots with small loads have achieved mass sales, and the six-axis robots with medium and large loads have begun to form mass sales.On the morning of December 12, 2024, the People's Court of Tongcheng County, Hubei Province publicly pronounced the case of Liu Gang, the former full-time vice chairman of Chengdu Football Association, for corruption, bribery and unit bribery, and sentenced the defendant Liu Gang to seven years in prison for corruption and fined 400,000 yuan. Sentenced to two years in prison for accepting bribes and fined 200,000 yuan; He was sentenced to one year's imprisonment and fined RMB 100,000 for bribery by a company, and decided to execute eight years' imprisonment and fined RMB 700,000. The property obtained from corruption shall be recovered according to law and returned to the injured unit respectively; The property obtained by taking bribes shall be recovered according to law and turned over to the state treasury.

Industrial Securities' investment strategy for the construction industry in 2025: internal and external resonance, optimistic about debt conversion and the "Belt and Road" industry, Industrial Securities Research Report said that the construction industry will face certain pressure in 2024, and it is expected that infrastructure investment will remain high in 2025, driven by the debt conversion policy. Review and prospect of plate market: central state-owned enterprises and design plates led the gains, with obvious excess returns. Main line 1: Debt conversion is expected to drive the improvement of the management quality of construction central enterprises. 1) The driving force and mode of action of this debt conversion can be compared with the "Belt and Road" market in 2014 and the PPP market in 2016, and the policy is driven from top to bottom. 2) The institutions' positions in construction central enterprises are low, and the valuation of construction central enterprises is also in the lower position of the historical center. 3) The unprecedented intensity of debt conversion will help the central enterprises to realize the double promotion of EPS and PE. Main Line 2: The Belt and Road Initiative is expected to accelerate and benefit international engineering enterprises. The "Belt and Road" market has accelerated its expansion, and international engineering enterprises are expected to accelerate their going out to sea, and their performance and valuation have both improved.List of A-share share repurchase: 16 companies disclosed the progress of repurchase, and on December 12, a total of 16 companies issued announcements related to share repurchase. Among them, four companies disclosed the stock repurchase plan for the first time, two companies' repurchase plans were approved by the shareholders' meeting, four companies disclosed the implementation progress of stock repurchase, and six companies' repurchase plans have been implemented. Judging from the initial disclosure of the repurchase plan, the amount of a company's stock repurchase plan on that day exceeded 10 million. Nanshan aluminum, Longzhu Science and Technology and Longzhu Science and Technology have the highest repurchase plans, and they plan to repurchase no more than 600 million yuan, 5,895,100 yuan and 1,171,000 yuan respectively. Judging from the repurchase plan passed by the shareholders' meeting, the repurchase plans of two companies exceeded 10 million on that day. Huaan Securities and Tongkun have the highest repurchase amount, with the planned repurchase not exceeding 200 million yuan and 51,966,700 yuan respectively. Judging from the implementation progress of repurchase, Shunluo Electronics, Shengquan Group and Hailiang have the highest repurchase amounts, with 9.009 million yuan, 3.8251 million yuan and 3.5187 million yuan respectively. Judging from the completed repurchase, the repurchase amount of four companies on that day exceeded 10 million. Chengda Pharmaceutical Co., Ltd., Jinshi Resources Co., Ltd. and Yingfangwei Co., Ltd. have completed the highest repurchase amounts, with 57,061,600 yuan, 53,158,000 yuan and 31,405,600 yuan respectively.CITIC Securities: The interest rate of the 10-year US bond may show an upward trend due to factors such as monetary policy next year. According to the CITIC Securities Research Report, historically, the actual short-term interest rate expectation in the interest rate reduction cycle since 1983 is usually the main driving force for the downward trend of the 10-year US bond interest rate, while the term premium may rise in the interest rate reduction cycle due to factors such as supply and demand, deficit concerns and external shocks. Looking forward to the future, it is expected that the short-term 4.0% will be the support level of the 10-year US bond interest rate, and the 10-year US bond interest rate may show an upward trend next year due to factors such as monetary policy and "Trump transaction".

Yin Xiyue denied that emergency martial law was a civil strife. South Korean President Yin Xiyue made a speech today (December 12), denying that "emergency martial law" was a "civil strife". He once again criticized the opposition party for enslaving Congress and abusing the power to impeach public officials. Yin Xiyue said that both impeachment and investigation will face it head-on.Citic Jiantou: We are optimistic about the investment opportunities in the pharmaceutical industry in 2025, focusing on the opportunities of new increase and industry integration. Citic Jiantou Securities reported on December 11th that looking forward to 2025, the reform policy in the pharmaceutical field has been normalized, and the most noteworthy incremental policy in the medical insurance field is to establish a diversified payment system. The medical field is about to usher in the reform of "deep water areas" such as salary system and graded diagnosis and treatment, which is in line with expectations on the whole. At the same time, the innovation of China's pharmaceutical industry has gradually stepped onto the international stage, some sub-sectors will be marginally improved, and industry integration will begin. We are optimistic about the investment opportunities in the pharmaceutical industry in 2025. It is suggested to focus on the new increase (innovation, going out to sea, marginal change) and industry integration opportunities.List of A-share share repurchase: 16 companies disclosed the progress of repurchase, and on December 12, a total of 16 companies issued announcements related to share repurchase. Among them, four companies disclosed the stock repurchase plan for the first time, two companies' repurchase plans were approved by the shareholders' meeting, four companies disclosed the implementation progress of stock repurchase, and six companies' repurchase plans have been implemented. Judging from the initial disclosure of the repurchase plan, the amount of a company's stock repurchase plan on that day exceeded 10 million. Nanshan aluminum, Longzhu Science and Technology and Longzhu Science and Technology have the highest repurchase plans, and they plan to repurchase no more than 600 million yuan, 5,895,100 yuan and 1,171,000 yuan respectively. Judging from the repurchase plan passed by the shareholders' meeting, the repurchase plans of two companies exceeded 10 million on that day. Huaan Securities and Tongkun have the highest repurchase amount, with the planned repurchase not exceeding 200 million yuan and 51,966,700 yuan respectively. Judging from the implementation progress of repurchase, Shunluo Electronics, Shengquan Group and Hailiang have the highest repurchase amounts, with 9.009 million yuan, 3.8251 million yuan and 3.5187 million yuan respectively. Judging from the completed repurchase, the repurchase amount of four companies on that day exceeded 10 million. Chengda Pharmaceutical Co., Ltd., Jinshi Resources Co., Ltd. and Yingfangwei Co., Ltd. have completed the highest repurchase amounts, with 57,061,600 yuan, 53,158,000 yuan and 31,405,600 yuan respectively.